Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2175 to 2224 of 8289 in total
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1088\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tax interaction protein 1. [source:refseq;acc:nm\_014604]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5732.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6256.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09139\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8012.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8310.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03723\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1089\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8387.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8699.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03722\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine--pyruvate aminotransferase (ec 2.6.1.51) (spt) (alanine-- glyoxylate aminotransferase) (ec 2.6.1.44) (agt). [source:swissprot;acc:p21549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6390.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6973.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0912\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1090\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8271.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8579.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03722\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5651.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6164.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09086\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1091\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 2 (vamp-2) (synaptobrevin 2). [source:swissprot;acc:p19065]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03718\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1092\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicule-associated membrane protein 4 (vamp-4). [source:swissprot;acc:o75379]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03718\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1093\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8276.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8584.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03717\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1094\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 1 (vamp-1) (synaptobrevin 1). [source:swissprot;acc:p23763]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.38\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03717\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1095\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nit protein 2. [source:refseq;acc:nm\_020202]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8056.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.41\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1096\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj470l14.3 (novel protein similar to the arp2/3 protein complex subunit p21-arc (arc21)). [source:sptrembl;acc:q9h5b6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7832.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8123.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03716\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5356.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5842.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09072\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homolog of yeast maf1. [source:refseq;acc:nm\_032272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 3 (vamp-3) (synaptobrevin 3) (cellubrevin) (ceb). [source:swissprot;acc:q15836]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03716\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin b receptor (integral nuclear envelope inner membrane protein) (lmn2r). [source:swissprot;acc:q14739]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7997.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8294.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03715\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 2. [source:refseq;acc:nm\_178865]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7832.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8123.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03715\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 1 (transmembrane protein sbbi99). [source:swissprot;acc:q13530]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed 1 protein like. [source:swissprot;acc:q9nrx5]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit c (ec 3.6.3.14) (v-atpase c subunit) (vacuolar proton pump c subunit). [source:swissprot;acc:p21283]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8001.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8298.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03714\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1101\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
d-3-phosphoglycerate dehydrogenase (ec 1.1.1.95) (3-pgdh). [source:swissprot;acc:o43175]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8237.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8543.49\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03714\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1102\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7833.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8124.21\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5462.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5958.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09066\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1103\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acid ceramidase precursor (ec 3.5.1.23) (acylsphingosine deacylase) (n-acylsphingosine amidohydrolase) (ac) (putative 32 kda heart protein) (php32). [source:swissprot;acc:q13510]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8103.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8403.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03714\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-62 antigen (fragment). [source:sptrembl;acc:q9y590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5358.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5843.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09062\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1104\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate carboxypeptidase-like protein 2 precursor. [source:swissprot;acc:q96kn2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8306.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8614.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03713\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5359.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5844.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09054\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1105\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptotagmin xii (sytxii). [source:swissprot;acc:q8iv01]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5460.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5954.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09049\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
werner helicase interacting protein isoform 1; putative helicase ruvbl; werner helicase interacting protein. [source:refseq;acc:nm\_020135]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8190.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8494.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03712\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1106\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase mitochondrial f1 complex assembly factor 2. [source:refseq;acc:nm\_145691]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7860.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8151.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0371\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1107\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bardet-biedl syndrome 7 protein isoform a; bbs2-like 1. [source:refseq;acc:nm\_176824]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7585.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7867.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0371\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1108\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8296.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8603.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0371\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rrp5 protein homolog (programmed cell death protein 11). [source:swissprot;acc:q14690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4846.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5283.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09016\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1109\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7070.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7332.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03708\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rab3a interacting protein (rabin3)-like 1. [source:refseq;acc:nm\_013401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6545.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7132.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08979\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1110\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40 kda peptidyl-prolyl cis-trans isomerase (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin-40) (cyp-40) (cyclophilin-related protein). [source:swissprot;acc:q08752]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8320.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8628.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03707\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadph:adrenodoxin oxidoreductase, mitochondrial precursor (ec 1.18.1.2) (adrenodoxin reductase) (ar) (ferredoxin-nadp(+) reductase). [source:swissprot;acc:p22570]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5947.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6481.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08979\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1111\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab3a interacting protein isoform alpha 1; rabin3; ssx2 interacting protein. [source:refseq;acc:nm\_022456]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6540.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7127.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08972\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm1 (small nuclear ribonuclear casm) (cancer-associated sm-like). [source:swissprot;acc:o15116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8002.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8299.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03705\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1112\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting 29 (vesicle protein sorting 29) (hvps29) (mds007) (pep11) (dc7/dc15). [source:swissprot;acc:q9ubq0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8057.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8355.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03705\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/